Investors Are Digesting These Healthcare Stock Earnings Insights

WellCare Health Plans, Inc. (NYSE:WCG) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 8.87% to $1.35 in the quarter versus EPS of $1.24 in the year-earlier quarter. Revenue Rose 28.76% to $2.33 billion from the year-earlier quarter.

WellCare Health Plans, Inc. reported adjusted EPS income of $1.35 per share. By that measure, the company beat the mean analyst estimate of $1.22. It beat the average revenue estimate of $2.28 billion.

WCG 20130811

Solta Medical, Inc. (NASDAQ:SLTM) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $0.02 in the quarter versus EPS of $-0.43 in the year-earlier quarter. Revenue Rose 15.94% to $43.2 million from the year-earlier quarter.

Solta Medical, Inc. reported adjusted EPS income of $0.02 per share. By that measure, the company beat the mean analyst estimate of $0. It missed the average revenue estimate of $45.97 million.

SLTM 20130811

Given Imaging Ltd. (NASDAQ:GIVN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 100% to $0.22 in the quarter versus EPS of $0.11 in the year-earlier quarter. Revenue Rose 11.21% to $49.5 million from the year-earlier quarter.

Given Imaging Ltd. reported adjusted EPS income of $0.22 per share. By that measure, the company beat the mean analyst estimate of $0.18. It beat the average revenue estimate of $48.23 million.

GIVN 20130811

VIVUS Inc. (NASDAQ:VVUS) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.55 in the quarter versus EPS of $-0.24 in the year-earlier quarter. Revenue Was the same at $5.53 million as the year-earlier quarter.

VIVUS Inc. reported adjusted EPS loss of $0.55 per share. By that measure, the company missed the mean analyst estimate of $-0.44. It missed the average revenue estimate of $12.76 million.

VVUS 20130811

Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-2.32 in the quarter versus EPS of $-2.09 in the year-earlier quarter. Revenue Decreased 77.06% to $3 million from the year-earlier quarter.

Furiex Pharmaceuticals, Inc. reported adjusted EPS loss of $2.32 per share. By that measure, the company missed the mean analyst estimate of $-1.65. It missed the average revenue estimate of $11.94 million.

FURX 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , , ,  

More from The Cheat Sheet